Wells Fargo & Company Ice Cure Medical Ltd. Call Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ICCM
# of Institutions
15Shares Held
361KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il170KShares$108,4870.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny66.4KShares$42,4960.0% of portfolio
-
Virtu Financial LLC New York, NY27.2KShares$17,4000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$16,3580.0% of portfolio
-
Two Sigma Investments, LP New York, NY21.3KShares$13,6030.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $23.6M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.